For prescribing information, click here

This website has been commissioned by Ipsen Pharmaceuticals Ltd. and is intended for Irish Healthcare Professionals. If you are not a Healthcare Professional, please click here.
Adverse event reporting information is available at the bottom of this webpage.

This website has been commissioned by Ipsen Pharmaceuticals Ltd. and is intended for an Irish audience

Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex)
Dysport<sup>®</sup> (<em>Clostridium botulinum</em> type A toxin-haemagglutinin complex)
All materials

Dysport® for urinary incontinence in adults with Neurogenic Detrusor Overactivity: HCP Booklet

Adult Spasticity File
8 pages

This leaflet is intended for healthcare professionals and covers key clinical trial data, dosing, dilution, and administration guidelines, when using botulinum neurotoxin for urinary incontinence in adults with neurogenic detrusor overactivity.

DYS-IE-001067 | January 2026

Dysport<sup>®</sup> for urinary incontinence in adults with Neurogenic Detrusor Overactivity: HCP Booklet
Explore more Adult Spasticity Resources

Explore more Adult Spasticity Resources

Browse

Adverse events should be reported.
Reporting forms and information can be found at www.hpra.ie or e-mail medsafety@hpra.ie.
The HPRA can also be contacted on +353 16764971. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256.

To access relevant information about Adult Spasticity, please choose one of the following options:

I am a healthcare professional in Ireland

This section is for healthcare professionals only. Contains promotional information

I am a healthcare professional in Ireland

Adverse events should be reported.
Reporting forms and information can be found at www.hpra.ie or e-mail medsafety@hpra.ie.
The HPRA can also be contacted on +353 16764971. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256.

I am a patient

This section provides information to support patients that have been prescribed Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

I am a patient

I am a member of the general public

This section is for members of the general public.

I am a member of the general public

Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly to the HPRA. Reporting forms and information can be found at www.hpra.ie or email medsafety@hpra.ie. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256. By reporting side effects, you can help provide more information on the safety of this medicine.